|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Kindred Biosciences, Inc.
| | | Phone: | (650) 701-7901 | Year Established: | 2012 | Employees: | 6 | Ticker: | KIN | Exchange: | NASDAQ | Main Contact: | Richard Chin, MD, Co-Founder & CEO | | Other Contacts: | Hangjun Zhan, PhD, CSO Wendy Wee, VP, Finance Denise Bevers, Co-Founder & President
| | Company Description | Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. | |
|
|
|
|
|